Here, we sought to determine whether T cells engineered to express PC–Gla–TACE–MMP–TRAP (PTMT) peptides on the surface and systemic release of therapeutics could be used as a possible treatment therapy for severe infectious diseases. This evidence concerns the gene GLA and infectious disease.